Sign in Pull a receipt

ELDN

Eledon Pharmaceuticals, Inc.

Healthcare · Biotechnology

$80.13 sample

+0.40 (+0.50%) 1D

Market cap

$451.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-30

Alerts

8

Price$80.13 +19.76% 3M daily closessample

80.3766.62

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: 10% owner
Oct 13INSInsider sell: General Counsel
Oct 05INSInsider buy: 10% owner
Sep 30SECDEF 14A filed
Sep 22INSInsider sell: Chief Executive Officer
Sep 16INSInsider sell: EVP, Operations
Sep 10SECDEF 14A filed
Sep 01INSInsider buy: 10% owner

Sign up to see the real ELDN record →

Company facts

SEC EDGAR registration

Name: Eledon Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -53sample, -100 to +100
Reporting currency: USD

Who is positioning in ELDN

sample

Insiders: 23 insider transactions over 90 days, net selling, $436.7M
Congress: 5 members traded over 90 days
Institutions · 13F: 18 funds hold $8.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$29.0B +16.4% y/y

Q4 2024Q3 2026

Inventory$17.3B +7.9% y/y

Q4 2024Q3 2026

Accounts receivable$12.6B +8.9% y/y

Q4 2024Q3 2026

Total debt$36.2B +16.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $190.5B +5.4% 3M
Sample peer B: $189.8B -12.0% 3M
Sample peer C: $209.3B +13.6% 3M
Sample peer D: $357.9B -2.3% 3M
Sample peer E: $310.6B +13.4% 3M